Connect with us

BIOTECH

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Is Never Out Of Focus

Published

on

GW Pharmaceuticals PLC- ADR

Latest R&D in the medical cannabis market is assisting industry leaders list breakthroughs and notable discoveries for advancing new patents and treatments for numerous applications aiming diseases including different forms of cancer and rare ailments. Cannabis firms in the markets with developments include one popular name and that is none other than GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).

The buzz

GW Pharmaceuticals closed down at $97.57.72 on Tuesday. The company reported back in May that that its results from a Phase III trial of Epidiolex® in children with Dravet syndrome were published in The New England Journal of Medicine. Epidiolex, the lead product candidate of GW and the prospective first in a new segment of anti-epileptic medications, is a liquid formulation of plant-derived Cannabidiol, a non-psychoactive Hemp, which is being analyzed for the treatment of numerous, grave pediatric-onset epilepsy ailments.

In the study, Epidiolex considerably lowered monthly convulsive seizure frequency versus placebo in highly treatment-resistant kids when added to current treatment. Epidiolex treatment was well taken, with a safety profile consistent with previous open label experience.

Another name in the list is CV Sciences Inc (OTCMKTS:CVSI) that finished Tuesday up slightly at $0.230 by the market close. The firm recently reported that it conducted its pre-IND meeting with the U.S. FDA on June 15, 2017, to assess its drug development plan for ‘CVSI-007’, the firm’s patent-pending offering for smokeless tobacco addiction treatment comprising of nicotine-polacrilex chewing gum together with synthetic Cannabidiol.

Michael J. Mona, Jr., the President and CEO of CV Sciences, expressed that their pre-IND discussions with the FDA was constructive and offered the firm with a favorable advancement roadmap for this vital combination drug candidate.

On Tuesday, another buzzing firm in the same sector, 22nd Century Group Inc (NYSEMKT:XXII) closed down at $1.79. The firm recently reported that, together with The UVA, it has introduced a project aimed at using unique ranges of industrial hemp to clean up and regain abandoned mine lands.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized1 day ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized1 day ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized5 days ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health2 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business2 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business2 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business2 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP2 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP2 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP2 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement